Skip to content

A Trimodal Prehabilitation Study for Patients Undergoing Major Abdominal Surgery

Trimodal Prehabilitation Programme Using Smart Watches and Mobile Applications in Patients Undergoing Major Abdominal Surgery: a Randomised Controlled Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04047524
Enrollment
30
Registered
2019-08-06
Start date
2019-05-14
Completion date
2019-12-28
Last updated
2019-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pilot Study

Brief summary

Prehabilitation programmes have the potential to reduce post-operative complications following abdominal cancer surgery by improving pre-operative fitness levels. Home-based prehabilitation programmes may be more cost effective than hospital-based programmes, but have issues with low compliance. The aims of our study are to assess whether mobile technologies such as smart watches and smartphone applications improve compliance with home-based prehabilitation programmes and to assess the effects of prehabilitation on pre-operative fitness levels in patients due to undergo major abdominal cancer surgery.

Detailed description

30 patients due to undergo major abdominal cancer surgery at The Christie NHS Foundation Trust will be enrolled to a pilot randomised controlled trial. They will randomised to either a home-based trimodal prehabilitation programme, delivered by the use of FitBit Smart Watches and Smartphone applications, or a control group who will receive a FitBit for physical activity monitoring only, for a period of 2-6 weeks prior to surgery. The prehabilitation programme will include exercise, nutritional, and psychological components. Study outcomes will include 6MWT (6-minute walk test), HADS (hospital anxiety and depression score), steps per day, length of stay post-operatively, and post-operative complications.

Interventions

OTHERMonitoring using a FitBit

Each participant will receive a Fitbit. The Prehabilitaiton Group will receive a Fitbit Charge 2 and they will be able to review their progress on this and be required to increase their exercise activity and input information and data about the exercise they have completed each day during their participation in the study. The Control group will receive a Fitbit Flex and will not be required to review any of their activity or input any data and will be encouraged to continue with their daily activity rates i.e. not to change.

Sponsors

The Christie NHS Foundation Trust
CollaboratorOTHER
Shira Baram
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Masking description

There is no masking. Both the investigator and participant will be aware of which arm they have been randomised to.

Intervention model description

Participants will be randomised sequentially i.e. 1:1 to receive either the Prehabilitation Programme or not

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* be aged 18 years or over * be able to consent to participate in the prehabilitation programme * be undergoing major abdominal cancer surgery (including, but not limited to, cytoreductive surgery with hyperthermic intraperitoneal chemotherapy) * have at least 2 weeks to their operation date * be able to understand written and spoken English

Exclusion criteria

* patients have any health conditions which will prevent them from safely taking part in a home-based exercise programme. For example, but not limited to, patients who have recently (within the past 3 months) had a myocardial infarction or a stroke or patients who have end-stage renal disease but are not on dialysis. We will use the Safety Reference Guide to support exercise services in people with cancer in The Lancet published paper Exercise as part of routine cancer care(5) to aid the screening of patients suitability. * they have any bone metastasis * are already active users of a FitBit device

Design outcomes

Primary

MeasureTime frameDescription
Quantitative data collected via a FitbitEach participant will be monitored for a period of 2-6 weeks pre surgeryData will be collected to determine the number of participants whose physical activity increased and by how much during the study

Secondary

MeasureTime frameDescription
Qualitative data collected by questionnaireEach participant will be monitored for a period of 2-6 weeks pre surgeryQualitative data will be collected from participants to identify their experience of the study
Quantitative data associated with participants weight at the start and end of the research interventionEach participant will be monitored for a period of 2-6 weeks pre surgeryParticipants weight will be measured in kilograms at the start of their participation and then prior to surgery to determine if they were able to either maintain their weight or gain weight

Countries

United Kingdom

Contacts

Primary ContactShira Baram
shira.baram@christie.nhs.uk0161 918 2098

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026